Possible scenario
Regulatory Review Emerges
24% Chance
The scale and timing of the CEO's sales make a regulatory review plausible, especially if investors complain about disclosures around 10b5-1 plans or public statements. A review does not imply wrongdoing, but it would likely extend the share-price overhang.
Tickers
- CRWV-4.8%
Portfolio impact
S&P 5000.0%
Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.
Keeping an eye on this scenario?
Tilt can alert you when its probability or impact shifts, or send you a recommendation when it crosses a threshold.